GABRG1

Chr 4

gamma-aminobutyric acid type A receptor subunit gamma1

The gamma-1 subunit forms part of GABA(A) receptors, heteropentameric chloride channels that mediate inhibitory neurotransmission in the brain by allowing chloride influx when activated by GABA. Mutations cause autosomal recessive early infantile epileptic encephalopathy-89, characterized by severe seizures beginning in early infancy. This gene is not highly constrained against loss-of-function variants, which is consistent with the recessive inheritance pattern observed in affected patients.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 0.81
Clinical SummaryGABRG1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
19 unique Pathogenic / Likely Pathogenic· 63 VUS of 87 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
0.81LOEUF
pLI 0.000
Z-score 2.22
OE 0.48 (0.290.81)
Tolerant

Typical tolerance to LoF variation

Missense Constraint
0.52Z-score
OE missense 0.91 (0.811.01)
220 obs / 242.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.48 (0.290.81)
00.351.4
Missense OE0.91 (0.811.01)
00.61.4
Synonymous OE1.20
01.21.6
LoF obs/exp: 10 / 21.0Missense obs/exp: 220 / 242.8Syn Z: -1.46
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedGABRG1-related epileptic encephalopathyOTHERAD
DN
0.85top 5%
GOF
0.82top 10%
LOF
0.2092th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

87 submitted variants in ClinVar

Classification Summary

Pathogenic18
Likely Pathogenic1
VUS63
Likely Benign1
18
Pathogenic
1
Likely Pathogenic
63
VUS
1
Likely Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
18
0
18
Likely Pathogenic
0
0
1
0
1
VUS
0
58
5
0
63
Likely Benign
0
0
0
1
1
Benign
0
0
0
0
0
Total05824183

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

GABRG1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →